Biosecurity, biobanking and data management during public health crises in Africa. A peer into the future.

Similar documents
Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

Impact of Pathology Implementation Strategies in Sub Saharan Africa

Scaling Up Nutrition Action for Africa

AIDS in Africa. An Update. Basil Reekie

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Food Production and Violent Conflict in Sub-Saharan Africa. - Supplementary Information -

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

Annex 2 A. Regional profile: West Africa

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

Addressing climate change driven health challenges in Africa

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

IMMUNIZATION VACCINES & EMERGENCIES

Children in Africa. Key statistics on child survival, protection and development

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Progress has been made with respect to health conditions.

CREOLE Study: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans. CREOLE Study

UNAIDS 2013 AIDS by the numbers

Update from GAVI Aurelia Nguyen

What is this document and who is it for?

Africa s slow fertility transition

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Fertility and Family Planning in Africa: Call for Greater Equity Consciousness

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Specific issues related to FMD surveillance in the eastern Africa sub-region. Gideon Brückner

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

Global reductions in measles mortality and the risk of measles resurgence

Incorporating combination polypharmacy into national or provincial CVD control strategies: An African perspective

Rift Valley Fever. What is Rift Valley Fever?

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Age-Sex Structure for Selected African countries in the early 2000s

Common EQA Mistakes - A provider Perspective. Experience from East African Regional External Quality Assessment Scheme (EA-REQAS)

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

Ageing and mental health resources for older persons in the African region of the World Health Organization

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

Global summary of the AIDS epidemic, December 2007

ASLM Building laboratory capacity in Africa in a sustainable way

Aboubacar Kampo Chief of Health UNICEF Nigeria

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

Towards an Atlas of Human Helminth Infection in sub-saharan Africa: The Use of Geographical Information Systems (GIS)

CDER EDITORIAL Through this issue of the

World Organisation for Animal Health Protecting animals, Preserving our future 1

Ouagadougou Declaration

Comparative Analyses of Adolescent Nutrition Indicators

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES

Progress Towards the Child Mortality MDG in Urban Sub-Saharan Africa. Nyovani Janet Madise University of Southampton

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Financing the HIV response in sub- Saharan Africa from domestic sources: moving beyond a normative approach

Schistosomiasis Alan Fenwick

Yellow fever Vaccine investment strategy

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

Expert Paper No. 2011/13

Prioritizing Emergency Polio Eradication Activities

African Gender and Development Index

IMMUNIZATION VACCINE DEVELOPMENT

AFRICA. The continent of All challenges

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

SGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:

Lessons learned from the IeDEA West Africa Collaboration

Expert Group Meeting on the Regional Report for the African Gender and Development Index

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

FACT SHEET SUB-SAHARAN AFRICA

Health situation analysis in the African Region. Basic indicators 2006

AFRICAN GENDER EQUALITY AND WOMEN S EMPOWERMENT SCORECARD

Global Fund ARV Fact Sheet 1 st June, 2009

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

IMMUNIZATION VACCINE DEVELOPMENT

Eligibility List 2018

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Influenza Surveillance In the WHO African Region

MDGs to Agenda 2063/SDGs

Yellow fever laboratory capacity on-site assessments in Africa: preliminary findings

Okwen PM 1,2, Maweu IW 1,3, Ndimbum CN 1, Evina Danielle 2 Ongolo-Zogo Pierre 2, George Nel 4, Anastase Dzudzie 4, Dike Orji 4, Mayosi Bongani 4

Blood safety in Africa: Progress made during the last decade and major challenges for the Future

THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

Development Through a Gender Lens: Implications for Poverty Reduction and Energy Sector Strategies

Main global and regional trends

Experiences on Workforce Development in Other Regions

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

TURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY

Plan of Presentation

Race towards Sustainab. MD, PhD, FRSPH

511,000 (57% new cases) ~50,000 ~30,000

Impact Dashboard - October 2014

Value of post-licensure data to assess public health value Example of rotavirus vaccines

Global Fund Results Fact Sheet Mid-2011

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

Excellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association

Disease Prevention, Detection & Response During Public Health Emergencies

Distr.: GENERAL. E/ECA/COE/31/8 AU/CAMEF/EXP/8(VII) 10 February Addis Ababa, Ethiopia March Original: ENGLISH

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

Transcription:

Biosecurity, biobanking and data management during public health crises in Africa. A peer into the future. Akin Abayomi, EU BBMRI ERIC meeting, Brusells, April 2017

Public Health Crises and the era of Emerging Infectious Diseases (EID) in Africa.

What are the precipitating factors leading to EIDs and risk of PHEIC?

Demographics. Population expansion and environmental impacts

Our increasing and expanding urban cities will become fertile ground for disease epidemics

Natural heavy burden of endemic Infectious Diseases.

Human Resources: Quantity and Quality

Number of Persons Served Per Pathologist in sub-saharan Africa THE GAMBIA GUINEA BISSAU SENEGAL SIERRA LEONE MAURITANIA GUINEA LIBERIA COTE DTVOIRE MALI BURKINA GHANA BENIN TOGO NIGER NIGERIA CAMEROON CHAD CENTRAL AFRICAN REPUBLIC SUDAN SOUTH SUDAN ERITREA ETHIOPIA DJIBOUTI No Active Pathologist >5.0 million 2.5-5.0 million 1.0-2.5 million 500,000-1 million 200,000-500,000 Data Not Available EQUATORIAL GUINEA GABON ANGOLA DEMOCRATIC REP. OF REPUBLIC THE OF THE CONGO CONGO (ZAIRE) RWANDA BURUNDI ANGOLA MALAWI UGANDA KENYA TANZANIA SOMALIA Number of Persons Per Pathologist: UK: 15,108 US: 19,232 ZAMBIA NAMIBIA ZIMBABWE MOZAMBIQUE MADAGASCAR SOUTH AFRICA Walvis Bay BOTSWANA LESOTHO SOUTH AFRICA SWAZILAND

Infrastructure. Few well developed facilities are not servicing the populations

Laboratory in Yambuku, DR Congo (Zaire), 1976 Guido van der Groen Photo: Breman

Plasmapheresis in Yambuku, DR Congo, 1976 Margaretha Isaacson (RSA) in Mission Hospital Laboratory Photo: J. Breman

2015 West Africa

Exploitation, strife, corruption and conflict

Diamonds fueling civil strife

Basic Sanitation

Abnormal manipulation of agriculture and the Eco-system

Climate Impact

THE CLIMATE - LAND COVER - POPULATION - WATER RESOURCES CYCLE Climate Land Cover Changes in CO 2, Rainfall and Temperature LU CO 2, T, H 2 O Land Cover Change: Natural Veg. to Crops Need for Energy Water Resources Need for Food Need for Water Population Increase and Development Population Schulze, 2007; Idea: Harding & Kabat, 2007

Estimated Mortality Impacts of Climate Change: Year 2000 Estimated annual deaths due to climate change: malnutrition (~80K), diarrhoea (~50K), malaria (~20K), flooding (~3K) 14 WHO regions scaled according to estimated annual death rates due to the change in climate since c.1970. (Patz, Gibbs et al, 2007: based on McMichael, Campbell-Lendrum, Kovats, et al, 2004)

Climate Change: Multiplier of Conflicts and Regional Tensions Regions afflicted by problems due to environmental stresses: population pressure water shortage climate change affecting crops sea level rise pre-existing hunger armed conflict, current/recent From UK Ministry of Defence [May RM, 2007 Lowy Institute Lecture. Sydney]

EID and risk to National and Global Security. Real case scenarios, happening as we speak.

Minister for Health, Lagos. Dr Jide Idris

Lagos Mega City

Lagos City Metropolis 23 Million inhabitants.

EID currently or imminently in danger of causing public health Lassa Fever EBOLA Dengue Yellow Fever crises in Africa Risk Pandemic flu Enteric outbreak of MDR pathogens MENINGITIS

Lassa Fever (LHF) Has plagued West African countries for decades, perhaps centuries. Contributory to the widespread poverty. 300 000 cases and 5 000 deaths each year, it is one of the priority diseases for urgent research in the WHO blueprint. Control is made complex by the existence of at least 4 lineages of the virus and expansion of multiple small mammals reservoirs.

The West African Ebola Outbreak 28,000 reported cases 2013 to 2016 11,000 reported deaths 14,000 survivors

AMR MDR outbreak in Lagos January 2017 2000 students in an all girls school presented with abdominal pain fever diarrhea and vomiting. 3 deaths so far and several hospitalised Pathogens are a range of enteric bacteria demonstrating MDR super bug features

Profile of Lagos MDR Cases. CDC preliminary report. Patient 1: CULTURE : Campylobacter jejuni O:19 and Campylobacter coli SUSCEPTIBILITY: The Campylobacter identified were sensitive to Erythromycin, moderately sensitive to Imipenem and resistant to all other antimicrobial agents. Patient 2: CULTURE: Salmonella Heidelberg SUSCEPTIBILITY: Salmonella was sensitive to imipenem, resistant to all other antimicrobial agents. Patient X: CULTURE: Escherichia coli 0157:H7 (Shiga toxin producing) SUSCEPTIBILITY: Escherichia coli isolated sensitive to ceftriazone and imipenem, resistant to all other antimicrobial agents. Two remaining samples grew organisms that we are yet to completely identify and classify. Molecular and genetic studies are ongoing and results should be ready within a week.

Meningococcal Meningitis Annual outbreaks across the Sahel of West and central Africa Highly contagious by droplets Very high fatality Currently an outbreak spreading rapidly across Nigeria

Panic, breakdown in security, economic shut down and migration

Activity of Militant and illicit trade routes

Biological Agents and Bioterrorism-2 Biological agents can be used as weapons in: Biocrimes Bioterrorism Biowarfare Definition: North Atlantic Treaty Organization (NATO) defines a biological weapon as the provision of any infectious agent or toxin by any means of delivery in order to cause harm to humans, animals, or plants.

We know that about 12,000 people fly out of Nigeria daily to different corners of the globe, it could have had a devastating effect on the world if not rapidly contained.

A health threat anywhere is a health threat everywhere Global aviation network Source: The Lancet 380:9857, 1-7 Dec 2012, pp. 1946-55. www.sciencedirect.com/science/article/pii/s0140673612611519 Note: Air traffic to most places in Africa, regions of South America, and parts of central Asia is low. If travel increases in these regions, additional introductions of vector-borne pathogens are probable